Welcome to the e-CCO Library Archive!

Filter:

P427. Non-adherence and 5-ASA switches in stable IBD patients are associated with increased risk of relapse

A. Robinson¹, M. Hankins², G. Wiseman³, M. Jones⁴, ¹Salford Royal NHS Foundation Trust, Salford, United Kingdom, ²University of Southampton, Southampton, United Kingdom, ³Medical Affairs, Warner Chilcott UK Ltd, Weybridge, United Kingdom, ⁴Health Informatics Research, Sciensus Ltd, Brighton, United Kingdom

Fecal microbiota transplantation in refractory pediatric UC - preliminary data.

K. Karolewska-Bochenek^*1, I. Lazowska-Przeorek¹, P. Grzesiowski², A. Banaszkiewicz¹, P. Albrecht¹, A. Gawronska¹, A. Radzikowski¹, M. Kotowska¹

¹Medical University of Warsaw, Department of Pediatric Gastroenterology & Nutrition, Warsaw, Poland, ²Fundacji Instytut Profilaktyki Zakazen, Fundacji Instytut Profilaktyki Zakazen, warsaw, Poland

Long-term clinical outcomes of Korean patients with Crohn's disease

S.Y. Choi¹, N.H. Kim¹, Y.S. Jung¹, C.M. Moon¹, S.Y. Lee¹, E.R. Kim², Y.H. Kim², C.K. Lee³, S.H. Lee⁴, J.H. Kim⁵, K.C. Huh⁶, S.A. Jung⁷, S.M. Yoon⁸, H.J. Song⁹, S.J. Boo⁹, H.J. Jang¹⁰, Y.S. Kim¹¹, K.M. Lee¹², J.E. Shin¹³, D.I. Park¹, ¹Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Internal medicine, Seoul, South Korea, ²Samsung Medical Center, Sungkyunkwan University School of Medicine, Medicine, Seoul, South Korea, ³Kyung Hee University School of Medicine, Internal medicine, Seoul, South Korea, ⁴Soonchunhyang University College of Medicine, Internal medicine, Cheonan, South Korea, ⁵Dongguk University College of Medicine, Internal medicine, Goyang, South Korea, ⁶Konyang University College of Medicine, Internal medicine, Daejeon, South Korea, ⁷Ewha Womans University, Internal medicine, Seoul, South Korea, ⁸Chungbuk National University Hospital, Internal medicine, Cheongju, South Korea, ⁹Jeju National University School of Medicine, Internal medicine, Jeju, South Korea, ¹⁰Hallym University Hangang Sacred Heart Hospital, Internal medicine, Seoul, South Korea, ¹¹Seoul Paik Hospital, Inje University College of Medicine, Internal medicine, Seoul, South Korea, ¹²St. Vincent's Hospital, The Catholic University of Korea College of Medicine, Internal medicine, Suwon, South Korea, ¹³Dankook University College of Medicine, Internal medicine, Cheonan, South Korea

P428. A record-linkage study of maternal perinatal outcomes in patients with inflammatory bowel disease in Oxford, from 1970–1989

P428. New opportunities overcoming of the secondary inefficiencies of the anticytokine therapy in patients with inflammatory bowel disease

O. Knyazev¹, V. Sagynbaeva¹, I. Ruchkina¹, A. Parfenov¹, P. Shcherbakov¹, A. Konoplyannikov², L. Lazebnik³, ¹Central Research Institute of Gastroenterology, Moscow, Russian Federation, ²Medical Radiological Research Center, Obninsk, Russian Federation, ³Clinical Hospital 33 of Moscow City, Moscow, Russian Federation

Rescue therapy with anti-TNF therapy in patients with Crohn's Disease and post-operative recurrence with intolerance or failure of thiopurines

B. Oller*¹, M. Mañosa¹, Y. Zabana¹, M. Piñol², J. Troya², J. Boix¹, V. Moreno¹, E. Cabré^{1, 3}, E. Domenech^{1, 3}

¹Hospital Universitari Germans Trias I Pujol, Gastroenterology, Badalona, Spain, ²Hospital Universitari Germans Trias I Pujol, General Surgery, Badalona, Spain, ³CIBEREHD, Gastroenterology, Barcelona, Spain

Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study

Y.S. Kim¹, Y.-H. Kim², J.S. Kim³, J.h. Cheon⁴, B.D. Ye⁵, H.J. Jung¹, S.J. Park⁴, S.-A. Jung⁶, Y.S. Park⁷, C.H. Choi⁸, K.O. Kim⁹, B.I. Jang⁹, D.S. Han¹⁰, S.-K. Yang⁵, W.H. Kim⁴, ¹Inje University College of Medicine, Internal Medicine, Seoul, Korea, Republic of, ²Sungkyunkwan University School of Medicine, Internal Medicine, Seoul, Korea, Republic of, ³Seoul National University College of Medicine, Internal Medicine, Seoul, Korea, Republic of, ⁴Yonsei University College of Medicine, Internal Medicine, Seoul, Korea, Republic of, ⁵University of Ulsan College of Medicine, Internal Medicine, Seoul, Korea, Republic of, ⁶Ewha Womans University, Internal medicine, Seoul, South Korea, ⁷Eulji university, School of medicine, Department of Gastrieneteriology, Seoul, Korea, Republic of, ⁸Chung-Ang University College of Medicine, Internal Medicine, Seoul, Korea, Republic of, ⁹Yeungnam University College of Medicine, Internal Medicine, Daegu, Korea, Republic of, ¹⁰Hanyang University Guri Hospital, Gastroenterology, Guri, Korea, Republic of

P429. Natural history of ulcerative colitis by the age group at diagnosis: a 10-year nationwide retrospective cohort from the Veterans Affairs healthcare system

A. Abbas¹, Y. Koleva², N. Khan², ¹Tulane University, Gastroenterology, New Orleans, United States, ²Southeast Louisiana Veterans Health Care System, Gastroenterology, New Orleans, United States

P429. Risk of inflammatory bowel disease following bacille Calmette–Guérin and smallpox vaccination: A population-based Danish base-cohort study

Influence of Disease Course on Therapeutic Effect of IFX in Crohn's disease

Q. Yang*, X. Gao, M. Zhi, J. Tang, N. Ding, P. Hu

The Sixth Affiliated Hospital of Sun Yat-sen University(Guangdong Gastrointestinal Hospital), Department of Gastroenterology, Guangzhou, China

Long-term outcome of Crohn's disease patients treated with infliximab

B.L. Chen, S.C. Lv, T. Feng, M.Y. Li, P.S. Rao, Z.R. Zeng, P.J. Hu, M.H. Chen, First Affiliated Hospital of Sun Yat-Sen University, Department of Gastroenterology, Guangzhou, China

P430. Colorectal cancer in inflammatory bowel diseases: A population-based study (1976–2008)

P430. Non-adherence to treatment in inflammatory bowel disease – prevalence and risk factors

J. Magalhães¹, F. Dias de Castro¹, M.J. Moreira¹, S. Leite¹, J. Cotter¹, ¹Alto Ave Hospital Center, Gastroenterology, Guimarães, Portugal

Assessment of safety and efficacy of biosimilar infliximab in children with Crohn disease: a preliminary report.

J. Sieczkowska*¹, A. Banaszkiewicz², A. Plocek³, D. Jarzebicka¹, A. Gawronska², E. Toporowska-Kowalska³, J. Kierkus¹

¹The Children’s Memorial Health Institute, Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, Warsaw, Poland, ²Medical University of Warsaw, Department of Pediatric Gastroenterology and Nutrition, Warsaw, Poland, ³Medical University of Łódź, Department of Paediatric Allergology, Gastroenterology and Nutrition, Łódź, Poland

Long-term efficacy of maintenance therapy with thiopurines in Crohn's disease

Y. Qiu, R. Mao, B.-l. Chen, Y. He, Z.-r. Zeng, M.-h. Chen, First Affiliated Hospital of Sun Yat-Sen University, Department of Gastroenterology, Guangzhou, China

P431. Clinical epidemiology and phenotypic characteristics of Crohn's disease in Saudi Arabia

P431. Microscopic severity is related to earlier surgery in newly diagnosed CD patients: results from the DELTA cohort

V. Nuij¹, C. Looman², M. Rijk³, R. Beukers⁴, R. Ouwendijk⁵, R. Quispel⁶, A. van Tilburg⁷, T. Tang⁸, H. Smalbraak⁹, K. Bruin¹⁰, F. Lindenburg¹¹, L. Peyrin-Biroulet¹², C.J. van der Woude¹³, ¹Erasmus Medical Center, Gastroenterology and Hepatology, Rotterdam, Netherlands, ²Erasmus Medical Center, Public Health, Rotterdam, Netherlands, ³Amphia Hospital, Gastroenterology & Hepatology, Breda, Netherlands, ⁴Albert Schweitzer Hospital, Gastroenterology & Hepatology, Dordrecht, Netherlands, ⁵Ikazia Hospital, Gastroenterology & Hepatology, Rotterdam, Netherlands, ⁶Reinier de Graaf Hospital, Gastroenterology and Hepatology, Delft, Netherlands, ⁷Sint Franciscus Gasthuis, Gastroenterology & Hepatology, Rotterdam, Netherlands, ⁸IJsselland Hospital, Gastroenterology & Hepatology, Capelle aan den IJssel, Netherlands, ⁹Lievensberg Hospital, Internal Medicine, Bergen op Zoom, Netherlands, ¹⁰Tweesteden Hospital, Gastroenterology & Hepatology, Tilburg, Netherlands, ¹¹Franciscus Hospital, Gastroenterology and Hepatology, Roosendaal, Netherlands, ¹²Nancy University Hospital, Université de Lorraine, Gastroenterology and Hepatology, Vandoeuvre-les-Nancy, France, ¹³Erasmus Medical Center, Department of Gastroenterology & Hepatology, Rotterdam, Netherlands

Serology panel for prediction relapse after discontinuation of infliximab in patients with Crohn's disease achieving clinical remission

K. Papamichail*^{1, 2}, K. Claes¹, M. de Bruyn¹, S. Hauenstein³, F. Princen³, S. Singh³, G.A. Van Assche¹, P.J. Rutgeerts¹, S. Vermeire¹, M. Ferrante¹

¹KU Leuven, Department of Clinical and Experimental Medicine, Translational Research Center for GastroIntestinal Disorders (TARGID), Leuven, Belgium, ²Evaggelismos Hospital, Gastroenterology Clinic, Athens, Greece, ³Prometheus Laboratories, Therapeutics & Diagnostics, San Diego, California, United States

Long term follow-up results of 14 patients with dominant stricture with PSC in IBD

M. Basaranoglu, I. Taskiran, E. Parlak, E. Kayacetin, Türkiye Yüksek Ihtisas Hospital, Gastroenterology, Ankara, Turkey

P432. Mesenchymal stromal cells did not increase the risk of infectious complications in patients with inflammatory bowel disease compared to treatment with infliximab

O. Knyazev¹, I. Ruchkina¹, A. Parfenov¹, Z. Mikhailova¹, P. Shcherbakov¹, L. Lazebnik², ¹Central Research Institute of Gastroenterology, Moscow, Russian Federation, ²Clinical Hospital 33 of Moscow City, Moscow, Russian Federation